Orthostatic Intolerance and the Headache Patient

Seminars in Pediatric Neurology

Volumn 17, Issue 2, 2010, Pages 109-116

  Mack, Kenneth J ^a   Johnson, Jonathan N ^a   Rowe, Peter C ^b  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; FLUDROCORTISONE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MIDODRINE; PYRIDOSTIGMINE; SEROTONIN UPTAKE INHIBITOR; THREO 3,4 DIHYDROXYPHENYLSERINE;

ABDOMINAL PAIN; AEROBIC EXERCISE; BLOOD PRESSURE MEASUREMENT; CHRONIC DAILY HEADACHE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH EDUCATION; HUMAN; HYPERTENSION; HYPOTENSION; LOW DRUG DOSE; NEURALLY MEDIATED HYPOTENSION; ONSET AGE; ORAL REHYDRATION THERAPY; ORTHOSTATIC HYPOTENSION; ORTHOSTATIC INTOLERANCE; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; REVIEW; STANDING; TREATMENT PLANNING;

ADOLESCENT; CHILD; HEADACHE; HUMANS; ORTHOSTATIC INTOLERANCE;

EID: 77953671725     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2010.04.006     Document Type: Review

References (81)

1. Low P.A., Sandroni P., Joyner M., et al. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 2009, 20:352-358.
2. Ganzeboom K.S., Colman N., Reitsma J.B., et al. Prevalence and triggers of syncope in medical students. Am J Cardiol 2003, 91:1006-1008.
3. Tanaka H., Fujita Y., Takenaka Y., et al. Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Pediatr Int 2009, 51:169-179.
4. Weiling W., Shepherd J.T. Initial and delayed circulatory responses to orthostatic stress in normal humans and in subjects with orthostatic intolerance. Int Angiol 1992, 11:69-82.
5. Smit A.A.J., Halliwill J.R., Low P.A., et al. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol 1999, 519:1-10.
6. Rowell L. Human Cardiovascular Control 1992, Oxford University Press, New York.
7. Schatz I.J., Bannister R. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996, 46:1470.
8. Tanaka H., Yamaguchi H., Matushima R., et al. Instantaneous orthostatic hypotension in children and adolescents: A new entity of orthostatic intolerance. Pediatr Res 1999, 46:691-696.
9. Rosen S.G., Cryer P.E. Postural tachycardia syndrome: Reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading. Am J Med 1982, 72:847-850.
10. Schondorf R., Low P.A. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?. Neurology 1993, 43:132-137.
11. MacLean A.R., Allen E.V. Orthostatic hypotension and orthostatic tachycardia: Treatment with the "head-up" bed. JAMA 1940, 115:2162-2167.
12. Stewart J.M., Gewitz M.H., Weldon A., et al. Patterns of orthostatic intolerance: The orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999, 135:218-225.
13. Kanjwal Y., Kosinski D., Grubb B.P. The postural orthostatic tachycardia syndrome: Definitions, diagnosis, and management. Pace 2003, 26:1747-1757.
14. Stewart J.M. Chronic orthostatic intolerance and the postural tachycardia syndrome. J Pediatr 2004, 145:725-730.
15. Garland E.M., Raj S.R., Black B.K., et al. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 2007, 69:790-799.
16. Raj S.R. The postural tachycardia syndrome (POTS): Pathophysiology, diagnosis and management. Indian pacing. Electrophys J 2006, 6:84-99.
17. Johnson J.N., Mack K.J., Kuntz N.L., et al. A clinical review. Pediatr Neurol 2010, 42:77-85.
18. Yamaguchi H., Tanaka H., Adachi K., et al. Beat-to-beat blood pressure and heart rate responses to active standing in Japanese children. Acta Paediatr 1996, 85:577-583.
19. Fouad F.M., Tadena-Thome L., Bravo E.L., et al. Idiopathic hypovolemia. Ann Intern Med 1986, 104:298-303.
20. Streeten D.H.P., Anderson G.H., Richardson R., et al. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: Evidence for excessive venous pooling. J Lab Clin Med 1988, 111:326-335.
21. Streeten D.H.P. Orthostatic intolerance. A historical introduction to the pathophysiological mechanisms. Am J Med Sci 1999, 317:78-87.
22. Raj S.R., Biaggioni I., Yamhure P.C., et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005, 111:1574-1582.
23. Stewart J.M., Weldon A. Vascular perturbations in the chronic orthostatic intolerance of the postural tachycardia syndrome. J Appl Physiol 2000, 89:1505-1512.
24. Mayuga K., Butters K.B., Fouad-Tarazi F. Early versus late postural tachycardia: A re-evaluation of a syndrome. Clin Auton Res 2008, 18:155-157.
25. Grubb B.P. Neurocardiogenic syncope. Syncope: Mechanisms and Management 2005, 47-71. Blackwell Futura, Malden, MA. B.P. Grubb, B. Olshansky (Eds.).
26. Stewart J.M. Postural tachycardia syndrome and reflex syncope: Similarities and differences. J Pediatr 2009, 154:481-485.
27. Sandroni P., Opfer-Gehrking B.E.E., Shen W.K., et al. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome. Clin Autonom Res 1996, 6:225-231.
28. Rowe P.C., Calkins H., deBusk K., et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: A randomized controlled trial. JAMA 2001, 285:52-59.
29. Masuki S., Eisenach J.H., Johnson C.P., et al. Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety. J Appl Physiol 2007, 102:896-903.
30. Raj V., Haman K.L., Raj S.R., et al. Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry 2009, 90:339-344.
31. Grubb B.P. Neurocardiogenic syncope. N Engl J Med 2005, 352:1004-1010.
32. Sra J.S., Jazayeri M.R., Dhala A., et al. Neurocardiogenic syncope: Diagnosis, mechanisms, and treatment. Cardiol Clin 1993, 11:183-191.
33. Ross B.A., Hughes S., Anderson E., et al. Abnormal responses to orthostatic testing in children and adolescents with recurrent unexplained syncope. Am Heart J 1991, 122:748-754.
34. Weiling W., Ganzeboom K.S., Saul J.P. Reflex syncope in children and adolescents. Heart 2004, 90:1094-1100.
35. Medow M.S., Stewart J.M., Sanyal S., et al. Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 2008, 16:4-20.
36. Jhanjee R., Can I., Benditt D.G. Syncope. Dis Mon 2009, 55:532-585.
37. van Lieshout J.J., Wieling W., Karemaker J.M., et al. The vasovagal response. Clin Sci 1991, 81:575-586.
38. Camfield P., Camfield C. Syncope in childhood: A case control clinical study of the familial tendency to faint. Can J Neurol Sci 1990, 17:306-308.
39. Mathias C., Deguchi K., Bleasdale-Barr K., et al. Frequency of family history in vasovagal syncope. Lancet 1998, 352:33-34.
40. Newton J., Kenny R., Lawson J., et al. Prevalence of family history in vasovagal syncope and haemodynamic response to head up tilt in first degree relatives. Clin Auton Res 2003, 13:22-26.
41. Benditt D.G., Ermie C., Padamilan B., et al. Catecholamine response during hemodynamically stable upright posture in individuals with and without tilt-table induced vasavagal syncope. Europace 2003, 5:65-70.
42. Sneddon J.F., Counihan P.J., Bashir Y., et al. Impaired immediate vasoconstrictor responses in patients with recurrent neutrally mediated syncope. Am J Cardiol 1993, 71:72-76.
43. Thompson H.L., Atherton J.J., Khafagi F.A., et al. Failure of reflex venoconstriction during exercise in patients with vasovagal syncope. Circulation 1996, 93:953-959.
44. Manyari D.E., Rose S., Tyberg J.V., et al. Abnormal reflex venous function in patients with neuromediated syncope. J Am Coll Cardiol 1996, 27:1730-1735.
45. Bechir M., Binggeli C., Corti R., et al. Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation 2003, 107:1620-1625.
46. Tanaka H., Yamaguchi H., Tamai H. Treatment of orthostatic intolerance with inflatable abdominal band. Lancet 1997, 349:175.
47. Streeten D.H.P., Thomas D., Bell D.S. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000, 320:1-8.
48. Rowe P.C., Bou-Holaigah I., Kan J.S., et al. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?. Lancet 1995, 345:623-624.
49. Bou-Holaigah I., Rowe P.C., Kan J., et al. Relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995, 274:961-967.
50. Freeman R., Komaroff A.L. Does the chronic fatigue syndrome involve the autonomic nervous system?. Am J Med 1997, 102:357-364.
51. De Lorenzo F., Hargreaves J., Kakkar V.V. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clin Autonom Res 1997, 7:185-190.
52. Schondorf R., Benoit J., Wein T., et al. Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999, 75:192-201.
53. Kenney R.A., Graham L.A. Chronic fatigue syndrome symptoms common in patients with vasovagal syncope. Am J Med 2001, 110:242-243. (letter).
54. Legge H., Norton M., Newton J.L. Fatigue is significant in vasovagal syncope and is associated with autonomic symptoms. Europace 2008, 10:1095-10155.
55. Goldstein D.S., Eldadah B., Holmes C., et al. Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation 2005, 111:839-845.
56. Rowe P.C., Barron D.F., Calkins H., et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 1999, 135:494-499.
57. Gazit Y., Nahir M., Grahame R., et al. Dysautonomia in the joint hypermobility syndrome. Am J Med 2003, 115:33-40.
58. Mack K.J. What incites new daily persistent headache in children?. Pediatr Neurol 2004, 31:122-125.
59. Kanjwal M.Y., Kosinski D.J., Grubb B.P. Treatment of postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia. Curr Cardiol Rep 2003, 5:402-406.
60. Sandroni P., Opfer-Gehrking T.L., McPhee B.R., et al. Postural tachycardia syndrome: Clinical features and follow-up study. Mayo Clin Proc 1999, 74:1106-1110.
61. Fischer P.R., Brands C.K., Porter C.J., et al. High prevalence of orthostatic intolerance in adolescents in a General Pediatric Referral Clinic. Clin Autonom Res 2005, 15:340.
62. Thieben M.J., Sandroni P., Sletten D.M., et al. Postural orthostatic tachycardia syndrome: The Mayo Clinic experience. Mayo Clin Proc 2007, 82:308-313.
63. Medow M.S., Stewart J.M. The postural tachycardia syndrome. Cardiol Rev 2007, 15:67-75.
64. Wyller V.B., Godang K., Morkrid L., et al. Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: Relation to clinical symptoms. Pediatrics 2007, 120:e129-e137.
65. Skinner J., Driscoll S.W., Fischer P.R., et al. Normal reference ranges for orthostatic changes in heart rate and blood pressure response in adolescents. Clin Autonom Res 2007, 17:307-308.
66. Sheldon R., Rose S., Ritchie D., et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol 2002, 40:142-148.
67. Mack K.J., Gladstein J. Management of chronic daily headache in children and adolescents. Paediatr Drugs 2008, 10:23-29.
68. El-Sayed H., Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 1996, 75:134-140.
69. Claydon V.E., Hainsworth R. Salt supplementation improves orthostatic cerebral and peripheral vascular control in patients with syncope. Hypertension 2004, 43:809-813.
70. Wieling W., van Lieshout J.J., van Leeuwen A.M. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Autonom Res 1993, 3:57-65.
71. Kuriachan V., Sheldon R.S., Platanov M. Evidence-based treatment for vasovagal syncope. Heart Rhythm 2008, 5:1609-1614.
72. Grubb B.P., Karabin B. Cardiology patient page. Postural tachycardia syndrome: Perspectives for patients. Circulation 2008, 118:e61-e62.
73. Raj S.R., Black B.K., Biaggioni I., et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: Less is more. Circulation 2009, 120:725-734.
74. Lai C.C., Fischer P.R., Brands C.K., et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol 2009, 32:234-238.
75. Qingyou Z., Junbao D., Chaoshu T. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr 2006, 149:777-780.
76. Vernino S., Sandroni P., Singer W., et al. Invited article: Autonomic ganglia: Target and novel therapeutic tool. Neurology 2008, 70:1926-1932.
77. Campo J.V., Perel J., Lucas A., et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: An exploratory study. J Am Acad Child Adolesc Psychiatry 2004, 43:1234-1242.
78. Ishitobi M., Haginoya K., Kitamura T., et al. Acute dysautonomia: Complete recovery after two courses of IVIG. Brain Dev 2004, 26:542-544.
79. Murali H.R., Mack K.J., Kuntz N.L. Acquired orthostatic intolerance and alpha 3 ganglionic acetylcholine antibodies in an adolescent girl. Clin Auton Res 2009, 19:298.
80. Burkhardt B.E., Pianosi P.T., Brands C.K., et al. Heart rate response to exercise in adolescents with autonomic dysfunction. Clin Autonom Res 2007, 17:266.
81. Mokri B., Low P.A. Orthostatic headaches without CSF leak in postural tachycardia syndrome. Neurology 2003, 14:980-982.